Verrica Pharmaceuticals Management
Management criteria checks 2/4
Verrica Pharmaceuticals' CEO is Jayson Rieger, appointed in Nov 2024, has a tenure of 8.92 years. directly owns 1.23% of the company’s shares, worth $497.50K. The average tenure of the management team and the board of directors is 4.3 years and 7.7 years respectively.
Key information
Jayson Rieger
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 1.2% |
| Management average tenure | 4.3yrs |
| Board average tenure | 7.7yrs |
Recent management updates
Recent updates
The Price Is Right For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Even After Diving 49%
Oct 03
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 17With A 67% Price Drop For Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) You'll Still Get What You Pay For
Aug 16Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?
Jul 21Is Verrica Pharmaceuticals (NASDAQ:VRCA) Using Debt In A Risky Way?
Jan 11Here's Why We're Not At All Concerned With Verrica Pharmaceuticals' (NASDAQ:VRCA) Cash Burn Situation
Jun 28We're Hopeful That Verrica Pharmaceuticals (NASDAQ:VRCA) Will Use Its Cash Wisely
Feb 05Vectoring Back In On Verrica Pharmaceuticals
Aug 31Verrica Pharmaceuticals reports insider buying
Jul 06Verrica Pharmaceuticals stock slides on proposed share offering
Jun 29Verrica Pharmaceuticals Should Receive Second CRL Today
May 24Auditors Have Doubts About Verrica Pharmaceuticals (NASDAQ:VRCA)
Mar 07Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Mar 06Time To Worry? Analysts Just Downgraded Their Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Outlook
Dec 17FDA extends review period for Verrica Pharmaceuticals' VP-102 NDA
May 28Verrica Pharmaceuticals EPS beats by $0.32
May 07CEO
Jayson Rieger (48 yo)
no data
Tenure
Dr. Jayson M. Rieger, Ph D., M.B.A., is President, CEO & Director of Verrica Pharmaceuticals Inc. from November 5, 2024. Dr. Rieger serves as Non-Executive Independent Director at Lytix Biopharma AS since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Legal Officer | 6.2yrs | US$2.56m | 0.14% $ 58.5k | |
| President | no data | no data | 1.23% $ 497.5k | |
| Interim CFO | no data | no data | no data | |
| Chief Medical Officer | 4.3yrs | US$989.18k | 0.12% $ 48.3k | |
| Executive Vice President of Technical Operations | 5.1yrs | no data | no data | |
| Head of Drug Development | 4.3yrs | no data | no data |
4.3yrs
Average Tenure
50yo
Average Age
Experienced Management: VRCA's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 8.9yrs | no data | 1.23% $ 497.5k | |
| Independent Director | 6.5yrs | US$119.19k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.3yrs | US$119.19k | 0% $ 0 | |
| Director | 8.9yrs | no data | 1.01% $ 411.3k | |
| Chairman of the Board | 8.9yrs | no data | 29.71% $ 12.1m | |
| Director | 6.5yrs | US$3.50m | 0.23% $ 92.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
7.7yrs
Average Tenure
58yo
Average Age
Experienced Board: VRCA's board of directors are considered experienced (7.7 years average tenure).